Therefore, TDG promotes the ubiquitination and degradation of DNMT3A by binding to it, decreasing the methylation level of the TIMP2 promoter, increasing the transcription and expression of TIMP2, and inhibiting the migration and invasion abilities of human CRC cells. The gene discussed is TIMP2; the disease is colorectal carcinoma.